Toxicity and response criteria of the Eastern Cooperative Oncology Group.

作者信息

Oken M M, Creech R H, Tormey D C, Horton J, Davis T E, McFadden E T, Carbone P P

出版信息

Am J Clin Oncol. 1982 Dec;5(6):649-55.

DOI:

PMID:7165009

Abstract

摘要

相似文献

[1]

Toxicity and response criteria of the Eastern Cooperative Oncology Group.

Am J Clin Oncol. 1982-12

[2]

Evaluation and Regulation of Oncology Drug Approval: Finding the Right Balance.

JAMA Oncol. 2016-6-1

[3]

Comprehensive criteria for assessing therapy-induced toxicity.

Cancer Invest. 1990

[4]

Advisory Group recommendations on priorities for the IARC Monographs.

Lancet Oncol. 2019-6

[5]

Criticism of tumor response criteria raises trial design questions.

J Natl Cancer Inst. 2006-2-15

[6]

Pilot studies and new agent programs of the Eastern Cooperative Oncology Group.

Cancer Treat Rep. 1980

[7]

Assessment of toxicity in cooperative oncology clinical trials: the long and short of it.

J Oncol Manag. 2002

[8]

Comparisons of Cooperative Group evaluation criteria for multiple-drug therapy for breast cancer.

Cancer Treat Rep. 1980

[9]

Drug trials in pediatric oncology: a multi-facetted problem.

Int J Clin Pharmacol Ther. 1998-11

[10]

Phase II study of lonidamine in patients with metastatic breast cancer. An Eastern Cooperative Oncology Group study.

Invest New Drugs. 1990-11

引用本文的文献

[1]

Assessing the need for multimodal care in anorexia and cachexia patients with advanced cancer referred to palliative care: a secondary analysis of a multicenter survey in Japan.

Support Care Cancer. 2025-9-6

[2]

Comparison of clinical characteristics and survival between HER2-zero and HER2-low in early breast cancer: a retrospective observational study.

Clin Transl Oncol. 2025-9-3

[3]

Modern approach to hepatocellular carcinoma treatment.

World J Hepatol. 2025-8-27

[4]

Individualized treatment of nasopharyngeal carcinoma with lung metastasis in an elderly patient: A case report.

Oncol Lett. 2025-8-19

[5]

External validation of deep learning-derived 18F-FDG PET/CT delta biomarkers for loco-regional control in head and neck cancer.

Acta Oncol. 2025-8-30

[6]

Does palliative care improve the quality of life for cancer patients in three tertiary hospitals in South Africa?

BMC Palliat Care. 2025-8-28

[7]

Profiling of psychoneurological symptoms in newly diagnosed head and neck cancer patients.

Support Care Cancer. 2025-8-29

[8]

Correlation Between MRI and Histopathology in Assessing Treatment Response to Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer.

Cancer Rep (Hoboken). 2025-9

[9]

From MINI to Meaningful Change-A German Pilot Study to Improve Patient Outcomes in End-of-Life Care.

Healthcare (Basel). 2025-8-16

[10]

Efficacy and Safety of the Combination of Durvalumab Plus Gemcitabine and Cisplatin in Patients with Advanced Biliary Tract Cancer: A Real-World Retrospective Cohort Study.

Biomedicines. 2025-8-6

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

新学期，新优惠

Toxicity and response criteria of the Eastern Cooperative Oncology Group.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

推荐工具

Suppr 超能文献

相似文献

引用本文的文献